Dissemination and genome analysis of high-level ceftriaxone-resistant penA 60.001 Neisseria gonorrhoeae strains from the Guangdong Gonococcal antibiotics susceptibility Programme (GD-GASP), 2016-2019
Background: After Neisseria gonorrhoeae FC428 was first found in Japan, ceftriaxone-resistant strains disseminated globally, and the gonococcal resistance rate increased remarkably. Epidemiological investigations are greatly significant for the analysis of antimicrobial resistance (AMR) trends, mole...
Saved in:
Published in | Emerging microbes & infections Vol. 11; no. 1; pp. 344 - 350 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Taylor & Francis
01.12.2022
Taylor & Francis Ltd Taylor & Francis Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background: After Neisseria gonorrhoeae FC428 was first found in Japan, ceftriaxone-resistant strains disseminated globally, and the gonococcal resistance rate increased remarkably. Epidemiological investigations are greatly significant for the analysis of antimicrobial resistance (AMR) trends, molecular features and evolution. Objectives: To clarify the AMR trend from 2016-2019 and reveal the molecular characteristics and evolution of ceftriaxone-resistant penA 60.001 isolates. Methods: The minimum inhibitory concentrations (MICs) of antibiotics against 4113 isolates were detected by the agar dilution method. N. gonorrhoeae multiantigen sequence typing (NG-MAST), multilocus sequence typing (MLST) and N.gonorrhoeae sequence typing for antimicrobial resistance (NG-STAR) were used to identify the sequence types. Genome analysis was conducted to analyze resistance genes, virulence factors, and evolutionary sources. Results: Isolates with decreased ceftriaxone susceptibility have increased from 2.05% (2016) to 16.18% (2019). Six ceftriaxone-resistant isolates possessing penA 60.001 appeared in Guangdong Province, and were resistant to ceftriaxone, penicillin, tetracycline, ciprofloxacin and cefixime, but susceptible to azithromycin and spectinomycin. Single-nucleotide polymorphisms (SNPs) in the porB gene were the major cause of different NG-MAST types. ST1903 was the main NG-STAR genotype and only strain-ZH545 was ST7365, with molecular features consistent with the MICs. Furthermore, different MLSTs suggested diverse evolutionary sources. Genome analysis revealed a set of virulence factors along with the resistance genes "penA" and "blaTEM-1B". Half of penA 60.001 strains were fully mixed with global FC428-related strains. Conclusions: Global FC428-related clones have disseminated across Guangdong, possibly causing decreased ceftriaxone susceptibility. Enhanced gonococcal surveillance will help elucidate the trajectory of transmission and curb further dissemination. |
---|---|
AbstractList | After
FC428 was first found in Japan, ceftriaxone-resistant strains disseminated globally, and the gonococcal resistance rate increased remarkably. Epidemiological investigations are greatly significant for the analysis of antimicrobial resistance (AMR) trends, molecular features and evolution.
To clarify the AMR trend from 2016-2019 and reveal the molecular characteristics and evolution of ceftriaxone-resistant
60.001 isolates.
The minimum inhibitory concentrations (MICs) of antibiotics against 4113 isolates were detected by the agar dilution method.
multiantigen sequence typing (NG-MAST), multilocus sequence typing (MLST) and
sequence typing for antimicrobial resistance (NG-STAR) were used to identify the sequence types. Genome analysis was conducted to analyze resistance genes, virulence factors, and evolutionary sources.
Isolates with decreased ceftriaxone susceptibility have increased from 2.05% (2016) to 16.18% (2019). Six ceftriaxone-resistant isolates possessing
60.001 appeared in Guangdong Province, and were resistant to ceftriaxone, penicillin, tetracycline, ciprofloxacin and cefixime, but susceptible to azithromycin and spectinomycin. Single-nucleotide polymorphisms (SNPs) in the
gene were the major cause of different NG-MAST types. ST1903 was the main NG-STAR genotype and only strain-ZH545 was ST7365, with molecular features consistent with the MICs. Furthermore, different MLSTs suggested diverse evolutionary sources. Genome analysis revealed a set of virulence factors along with the resistance genes "
" and "
". Half of
60.001 strains were fully mixed with global FC428-related strains.
Global FC428-related clones have disseminated across Guangdong, possibly causing decreased ceftriaxone susceptibility. Enhanced gonococcal surveillance will help elucidate the trajectory of transmission and curb further dissemination. Background: After Neisseria gonorrhoeae FC428 was first found in Japan, ceftriaxone-resistant strains disseminated globally, and the gonococcal resistance rate increased remarkably. Epidemiological investigations are greatly significant for the analysis of antimicrobial resistance (AMR) trends, molecular features and evolution. Objectives: To clarify the AMR trend from 2016–2019 and reveal the molecular characteristics and evolution of ceftriaxone-resistant penA 60.001 isolates. Methods: The minimum inhibitory concentrations (MICs) of antibiotics against 4113 isolates were detected by the agar dilution method. N. gonorrhoeae multiantigen sequence typing (NG-MAST), multilocus sequence typing (MLST) and N.gonorrhoeae sequence typing for antimicrobial resistance (NG-STAR) were used to identify the sequence types. Genome analysis was conducted to analyze resistance genes, virulence factors, and evolutionary sources. Results: Isolates with decreased ceftriaxone susceptibility have increased from 2.05% (2016) to 16.18% (2019). Six ceftriaxone-resistant isolates possessing penA 60.001 appeared in Guangdong Province, and were resistant to ceftriaxone, penicillin, tetracycline, ciprofloxacin and cefixime, but susceptible to azithromycin and spectinomycin. Single-nucleotide polymorphisms (SNPs) in the porB gene were the major cause of different NG-MAST types. ST1903 was the main NG-STAR genotype and only strain-ZH545 was ST7365, with molecular features consistent with the MICs. Furthermore, different MLSTs suggested diverse evolutionary sources. Genome analysis revealed a set of virulence factors along with the resistance genes “penA” and “blaTEM-1B”. Half of penA 60.001 strains were fully mixed with global FC428-related strains. Conclusions: Global FC428-related clones have disseminated across Guangdong, possibly causing decreased ceftriaxone susceptibility. Enhanced gonococcal surveillance will help elucidate the trajectory of transmission and curb further dissemination. Background: After Neisseria gonorrhoeae FC428 was first found in Japan, ceftriaxone-resistant strains disseminated globally, and the gonococcal resistance rate increased remarkably. Epidemiological investigations are greatly significant for the analysis of antimicrobial resistance (AMR) trends, molecular features and evolution. Objectives: To clarify the AMR trend from 2016–2019 and reveal the molecular characteristics and evolution of ceftriaxone-resistant penA 60.001 isolates. Methods: The minimum inhibitory concentrations (MICs) of antibiotics against 4113 isolates were detected by the agar dilution method. N. gonorrhoeae multiantigen sequence typing (NG-MAST), multilocus sequence typing (MLST) and N.gonorrhoeae sequence typing for antimicrobial resistance (NG-STAR) were used to identify the sequence types. Genome analysis was conducted to analyze resistance genes, virulence factors, and evolutionary sources. Results: Isolates with decreased ceftriaxone susceptibility have increased from 2.05% (2016) to 16.18% (2019). Six ceftriaxone-resistant isolates possessing penA 60.001 appeared in Guangdong Province, and were resistant to ceftriaxone, penicillin, tetracycline, ciprofloxacin and cefixime, but susceptible to azithromycin and spectinomycin. Single-nucleotide polymorphisms (SNPs) in the porB gene were the major cause of different NG-MAST types. ST1903 was the main NG-STAR genotype and only strain-ZH545 was ST7365, with molecular features consistent with the MICs. Furthermore, different MLSTs suggested diverse evolutionary sources. Genome analysis revealed a set of virulence factors along with the resistance genes “ penA ” and “ blaTEM-1B ”. Half of penA 60.001 strains were fully mixed with global FC428-related strains. Conclusions: Global FC428-related clones have disseminated across Guangdong, possibly causing decreased ceftriaxone susceptibility. Enhanced gonococcal surveillance will help elucidate the trajectory of transmission and curb further dissemination. Background: After Neisseria gonorrhoeae FC428 was first found in Japan, ceftriaxone-resistant strains disseminated globally, and the gonococcal resistance rate increased remarkably. Epidemiological investigations are greatly significant for the analysis of antimicrobial resistance (AMR) trends, molecular features and evolution. Objectives: To clarify the AMR trend from 2016-2019 and reveal the molecular characteristics and evolution of ceftriaxone-resistant penA 60.001 isolates. Methods: The minimum inhibitory concentrations (MICs) of antibiotics against 4113 isolates were detected by the agar dilution method. N. gonorrhoeae multiantigen sequence typing (NG-MAST), multilocus sequence typing (MLST) and N.gonorrhoeae sequence typing for antimicrobial resistance (NG-STAR) were used to identify the sequence types. Genome analysis was conducted to analyze resistance genes, virulence factors, and evolutionary sources. Results: Isolates with decreased ceftriaxone susceptibility have increased from 2.05% (2016) to 16.18% (2019). Six ceftriaxone-resistant isolates possessing penA 60.001 appeared in Guangdong Province, and were resistant to ceftriaxone, penicillin, tetracycline, ciprofloxacin and cefixime, but susceptible to azithromycin and spectinomycin. Single-nucleotide polymorphisms (SNPs) in the porB gene were the major cause of different NG-MAST types. ST1903 was the main NG-STAR genotype and only strain-ZH545 was ST7365, with molecular features consistent with the MICs. Furthermore, different MLSTs suggested diverse evolutionary sources. Genome analysis revealed a set of virulence factors along with the resistance genes "penA" and "blaTEM-1B". Half of penA 60.001 strains were fully mixed with global FC428-related strains. Conclusions: Global FC428-related clones have disseminated across Guangdong, possibly causing decreased ceftriaxone susceptibility. Enhanced gonococcal surveillance will help elucidate the trajectory of transmission and curb further dissemination.Background: After Neisseria gonorrhoeae FC428 was first found in Japan, ceftriaxone-resistant strains disseminated globally, and the gonococcal resistance rate increased remarkably. Epidemiological investigations are greatly significant for the analysis of antimicrobial resistance (AMR) trends, molecular features and evolution. Objectives: To clarify the AMR trend from 2016-2019 and reveal the molecular characteristics and evolution of ceftriaxone-resistant penA 60.001 isolates. Methods: The minimum inhibitory concentrations (MICs) of antibiotics against 4113 isolates were detected by the agar dilution method. N. gonorrhoeae multiantigen sequence typing (NG-MAST), multilocus sequence typing (MLST) and N.gonorrhoeae sequence typing for antimicrobial resistance (NG-STAR) were used to identify the sequence types. Genome analysis was conducted to analyze resistance genes, virulence factors, and evolutionary sources. Results: Isolates with decreased ceftriaxone susceptibility have increased from 2.05% (2016) to 16.18% (2019). Six ceftriaxone-resistant isolates possessing penA 60.001 appeared in Guangdong Province, and were resistant to ceftriaxone, penicillin, tetracycline, ciprofloxacin and cefixime, but susceptible to azithromycin and spectinomycin. Single-nucleotide polymorphisms (SNPs) in the porB gene were the major cause of different NG-MAST types. ST1903 was the main NG-STAR genotype and only strain-ZH545 was ST7365, with molecular features consistent with the MICs. Furthermore, different MLSTs suggested diverse evolutionary sources. Genome analysis revealed a set of virulence factors along with the resistance genes "penA" and "blaTEM-1B". Half of penA 60.001 strains were fully mixed with global FC428-related strains. Conclusions: Global FC428-related clones have disseminated across Guangdong, possibly causing decreased ceftriaxone susceptibility. Enhanced gonococcal surveillance will help elucidate the trajectory of transmission and curb further dissemination. |
Author | Yu, Yuqi Wu, Xingzhong Xie, Qinghui Liao, Yiwen Tang, Sanmei Zheng, Heping Lin, Xiaomian Qin, Xiaolin Chen, Wentao Feng, Zhanjin |
Author_xml | – sequence: 1 givenname: Xiaomian orcidid: 0000-0002-7780-0458 surname: Lin fullname: Lin, Xiaomian organization: Southern Medical University – sequence: 2 givenname: Wentao surname: Chen fullname: Chen, Wentao organization: Southern Medical University – sequence: 3 givenname: Qinghui surname: Xie fullname: Xie, Qinghui organization: Southern Medical University – sequence: 4 givenname: Yuqi surname: Yu fullname: Yu, Yuqi organization: Southern Medical University – sequence: 5 givenname: Yiwen surname: Liao fullname: Liao, Yiwen organization: Southern Medical University – sequence: 6 givenname: Zhanjin surname: Feng fullname: Feng, Zhanjin organization: Southern Medical University – sequence: 7 givenname: Xiaolin surname: Qin fullname: Qin, Xiaolin organization: Southern Medical University – sequence: 8 givenname: Xingzhong surname: Wu fullname: Wu, Xingzhong organization: Southern Medical University – sequence: 9 givenname: Sanmei surname: Tang fullname: Tang, Sanmei organization: Southern Medical University – sequence: 10 givenname: Heping surname: Zheng fullname: Zheng, Heping email: zhengheping@smu.edu.cn organization: Southern Medical University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34994305$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUtFuFCEUnZgaW2s_QUPiS02cCswww8TE2LS6Nmm0ifpMGOYyS8PACmx1v9Dfkum2pu2D8nCBe889HOA8LXacd1AUzwk-IpjjNzQP0jJyRDGdAyEN4Y-KvTlfzoWdO-vd4iDGS5xHi5ua1E-K3aruurrCbK_4fWpihMk4mYx3SLoBjeD8BHkp7SaaiLxGSzMuSwtXYJECnYKRv7KgMkCuJ-kSWoE7Rg0-wpigzzBTZgwavfMhLD1IQDEFaVxEOvgJpSWgxVq6cfBuRIsMU14pafOhyfTGJ6MiiuuoYDXvrUkbdBH8GOSUlR0uTsvF8deLV69RvnpT5tA9Kx5raSMc3Mz7xfePH76dfCrPvyzOTo7PS8UamkrCWc96qnvoWtW0Q0-x7GQPQInWrG4Up5o3qtegqaoqaNnQ95qzqqVDxRte7RdnW97By0uxCmaSYSO8NOI64cMoZMjyLQhMmKKMcqZ6XlNGuqrPGgY-AOVtw5rM9W7LtVr3EwwKXH4je4_0fsWZpRj9leBtV-OGZILDG4Lgf6whJjGZ_GbWSgd-HQXNrqAVq3GVoS8fQC_9OuQvzqi25rhiTUsz6sVdRX-l3PolA95uASr4GANooUy6ts78vVYQLGaDiluDitmg4saguZs96L494H9977d9xmkfJvnTBzuIJDfWBx2kUyaK6t8UfwC6CfzW |
CitedBy_id | crossref_primary_10_1093_jac_dkad281 crossref_primary_10_1128_spectrum_03952_22 crossref_primary_10_1097_IM9_0000000000000158 crossref_primary_10_1097_IM9_0000000000000113 crossref_primary_10_1128_spectrum_02449_23 crossref_primary_10_1128_spectrum_03507_23 crossref_primary_10_3390_antibiotics13050468 crossref_primary_10_1016_S1473_3099_24_00001_X crossref_primary_10_1080_22221751_2023_2249124 crossref_primary_10_1093_jac_dkac202 crossref_primary_10_3389_fphar_2023_1291885 crossref_primary_10_1093_jacamr_dlad139 crossref_primary_10_1186_s12941_023_00587_x crossref_primary_10_3389_fmolb_2023_1258834 crossref_primary_10_1093_jac_dkad193 crossref_primary_10_2147_IDR_S408896 crossref_primary_10_2807_1560_7917_ES_2022_27_50_2200899 crossref_primary_10_2807_1560_7917_ES_2023_28_10_2300125 crossref_primary_10_3390_ijms23073550 crossref_primary_10_3390_microorganisms10122388 crossref_primary_10_1016_j_ijantimicag_2024_107101 crossref_primary_10_1097_JD9_0000000000000247 crossref_primary_10_1128_spectrum_02335_22 crossref_primary_10_1093_infdis_jiad258 crossref_primary_10_1080_22221751_2024_2440489 crossref_primary_10_1128_aac_02294_21 crossref_primary_10_1038_s41579_024_01023_3 crossref_primary_10_3390_ijms231810499 crossref_primary_10_1093_jac_dkac158 crossref_primary_10_1093_jac_dkae217 crossref_primary_10_1093_jac_dkad168 crossref_primary_10_1093_jac_dkae297 crossref_primary_10_3390_ijms25115781 |
Cites_doi | 10.1371/journal.pone.0220339 10.1016/S1473-3099(17)30753-3 10.3201/eid2507.190172 10.1186/s13073-021-00858-2 10.1093/jac/dkaa196 10.1093/bioinformatics/btz305 10.1097/OLQ.0000000000000859 10.1093/nar/gku1196 10.1128/AAC.00149-15 10.1016/S1369-5274(99)00008-9 10.1111/j.1365-2958.1994.tb00489.x 10.1128/AAC.46.3.769-777.2002 10.1128/mSphere.00977-20 10.1038/s41467-021-24072-1 10.1111/j.1462-5822.2009.01308.x 10.1093/molbev/msz189 10.1007/s40265-021-01530-0 10.1177/0956462420949126 10.1371/journal.pmed.1002499 10.15585/mmwr.mm6950a6 10.1074/jbc.RA119.009942 10.1073/pnas.92.17.7986 10.1038/s41572-019-0128-6 10.1128/mBio.00187-11 10.1099/mgen.0.000056 10.1016/j.ijantimicag.2019.08.015 10.1111/j.1365-2958.2006.05079.x 10.2471/BLT.18.228486 10.1128/AAC.00325-11 10.1111/mmi.12002 10.1128/IAI.00319-16 10.1093/jac/dkaa526 10.1093/jac/dkaa123 10.1093/jac/dkz530 |
ContentType | Journal Article |
Copyright | 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd 2022 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd. This work is licensed under the Creative Commons Attribution – Non-Commercial License http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd 2022 The Author(s) |
Copyright_xml | – notice: 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd 2022 – notice: 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd. This work is licensed under the Creative Commons Attribution – Non-Commercial License http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd 2022 The Author(s) |
DBID | 0YH AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1080/22221751.2021.2011618 |
DatabaseName | Taylor & Francis Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 0YH name: Taylor & Francis Open Access url: https://www.tandfonline.com sourceTypes: Publisher – sequence: 5 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
DocumentTitleAlternate | Emerging Microbes & Infections |
EISSN | 2222-1751 |
EndPage | 350 |
ExternalDocumentID | oai_doaj_org_article_015c25285cb8425193b562d8de287656 PMC8794061 34994305 10_1080_22221751_2021_2011618 2011618 |
Genre | Research Article Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GrantInformation_xml | – fundername: Medical Science and Technology Research Foundation of Guangdong Province grantid: B2020149 funderid: 10.13039/501100009330 – fundername: "Overseas Famous Teacher" Project of Guangdong Provincial Science and Technology Department grantid: 2020A1414010136 funderid: 10.13039/501100007162 – fundername: Guangdong Traditional Chinese Medicine Research Project grantid: 202105291302207230 |
GroupedDBID | 0YH 3V. 53G 5VS 7X7 88E 8FI 8FJ AAHBH ABUWG ACGFS ADBBV ADRAZ AENEX AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BENPR BPHCQ BVXVI C6C CCPQU DIK EBS ECGQY EMOBN FYUFA GROUPED_DOAJ HMCUK HYE KQ8 M1P M48 M4Z M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM TDBHL UKHRP AAYXX CITATION PHGZM PHGZT BCNDV CGR CUY CVF ECM EIF EJD NPM PJZUB PPXIY 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c562t-185b5b2fbe97c67db20a9abee21ff546c82f86cbfef2c33e75dbbf85372d38683 |
IEDL.DBID | 0YH |
ISSN | 2222-1751 |
IngestDate | Wed Aug 27 01:27:11 EDT 2025 Thu Aug 21 14:14:43 EDT 2025 Fri Jul 11 02:51:45 EDT 2025 Fri Jul 25 20:41:37 EDT 2025 Mon Jul 21 05:55:15 EDT 2025 Tue Jul 01 04:46:42 EDT 2025 Thu Apr 24 22:58:17 EDT 2025 Wed Dec 25 09:03:42 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | N. gonorrhoeae ceftriaxone-resistant epidemiological investigation penA 60.001 |
Language | English |
License | open-access: http://creativecommons.org/licenses/by-nc/4.0/: This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c562t-185b5b2fbe97c67db20a9abee21ff546c82f86cbfef2c33e75dbbf85372d38683 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Xiaomian Lin, Wentao Chen and Qinghui Xie contributed equally to this work. Supplemental data for this article can be accessed https://doi.org/10.1080/22221751.2021.2011618 |
ORCID | 0000-0002-7780-0458 |
OpenAccessLink | https://www.tandfonline.com/doi/abs/10.1080/22221751.2021.2011618 |
PMID | 34994305 |
PQID | 2748035672 |
PQPubID | 2041957 |
PageCount | 7 |
ParticipantIDs | crossref_citationtrail_10_1080_22221751_2021_2011618 proquest_journals_2748035672 pubmed_primary_34994305 crossref_primary_10_1080_22221751_2021_2011618 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8794061 proquest_miscellaneous_2618235403 informaworld_taylorfrancis_310_1080_22221751_2021_2011618 doaj_primary_oai_doaj_org_article_015c25285cb8425193b562d8de287656 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-Dec |
PublicationDateYYYYMMDD | 2022-12-01 |
PublicationDate_xml | – month: 12 year: 2022 text: 2022-Dec |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: London |
PublicationTitle | Emerging microbes & infections |
PublicationTitleAlternate | Emerg Microbes Infect |
PublicationYear | 2022 |
Publisher | Taylor & Francis Taylor & Francis Ltd Taylor & Francis Group |
Publisher_xml | – name: Taylor & Francis – name: Taylor & Francis Ltd – name: Taylor & Francis Group |
References | e_1_3_5_29_1 e_1_3_5_28_1 e_1_3_5_27_1 e_1_3_5_26_1 e_1_3_5_25_1 e_1_3_5_24_1 e_1_3_5_23_1 e_1_3_5_22_1 e_1_3_5_3_1 e_1_3_5_2_1 e_1_3_5_9_1 e_1_3_5_21_1 e_1_3_5_8_1 e_1_3_5_5_1 e_1_3_5_4_1 e_1_3_5_7_1 e_1_3_5_6_1 e_1_3_5_18_1 e_1_3_5_17_1 e_1_3_5_16_1 e_1_3_5_15_1 e_1_3_5_13_1 e_1_3_5_14_1 e_1_3_5_35_1 e_1_3_5_11_1 e_1_3_5_34_1 e_1_3_5_12_1 e_1_3_5_33_1 e_1_3_5_19_1 Unemo M (e_1_3_5_20_1) 2020; 2020 e_1_3_5_32_1 e_1_3_5_10_1 e_1_3_5_31_1 e_1_3_5_30_1 |
References_xml | – ident: e_1_3_5_22_1 doi: 10.1371/journal.pone.0220339 – ident: e_1_3_5_3_1 doi: 10.1016/S1473-3099(17)30753-3 – ident: e_1_3_5_6_1 doi: 10.3201/eid2507.190172 – ident: e_1_3_5_17_1 doi: 10.1186/s13073-021-00858-2 – ident: e_1_3_5_25_1 doi: 10.1093/jac/dkaa196 – ident: e_1_3_5_14_1 doi: 10.1093/bioinformatics/btz305 – ident: e_1_3_5_26_1 doi: 10.1097/OLQ.0000000000000859 – ident: e_1_3_5_12_1 doi: 10.1093/nar/gku1196 – ident: e_1_3_5_31_1 doi: 10.1128/AAC.00149-15 – ident: e_1_3_5_23_1 doi: 10.1016/S1369-5274(99)00008-9 – ident: e_1_3_5_30_1 doi: 10.1111/j.1365-2958.1994.tb00489.x – ident: e_1_3_5_21_1 doi: 10.1128/AAC.46.3.769-777.2002 – ident: e_1_3_5_33_1 doi: 10.1128/mSphere.00977-20 – ident: e_1_3_5_11_1 doi: 10.1038/s41467-021-24072-1 – ident: e_1_3_5_32_1 doi: 10.1111/j.1462-5822.2009.01308.x – ident: e_1_3_5_15_1 doi: 10.1093/molbev/msz189 – ident: e_1_3_5_5_1 doi: 10.1007/s40265-021-01530-0 – volume: 2020 start-page: 956462420949126 year: 2020 ident: e_1_3_5_20_1 article-title: European guideline for the diagnosis and treatment of gonorrhoea in adults publication-title: Int J STD AIDS doi: 10.1177/0956462420949126 – ident: e_1_3_5_18_1 doi: 10.1371/journal.pmed.1002499 – ident: e_1_3_5_19_1 doi: 10.15585/mmwr.mm6950a6 – ident: e_1_3_5_24_1 doi: 10.1074/jbc.RA119.009942 – ident: e_1_3_5_29_1 doi: 10.1073/pnas.92.17.7986 – ident: e_1_3_5_16_1 doi: 10.1038/s41572-019-0128-6 – ident: e_1_3_5_28_1 doi: 10.1128/mBio.00187-11 – ident: e_1_3_5_13_1 doi: 10.1099/mgen.0.000056 – ident: e_1_3_5_10_1 doi: 10.1016/j.ijantimicag.2019.08.015 – ident: e_1_3_5_27_1 doi: 10.1111/j.1365-2958.2006.05079.x – ident: e_1_3_5_2_1 doi: 10.2471/BLT.18.228486 – ident: e_1_3_5_4_1 doi: 10.1128/AAC.00325-11 – ident: e_1_3_5_34_1 doi: 10.1111/mmi.12002 – ident: e_1_3_5_35_1 doi: 10.1128/IAI.00319-16 – ident: e_1_3_5_9_1 doi: 10.1093/jac/dkaa526 – ident: e_1_3_5_8_1 doi: 10.1093/jac/dkaa123 – ident: e_1_3_5_7_1 doi: 10.1093/jac/dkz530 |
SSID | ssj0000706414 |
Score | 2.4292583 |
Snippet | Background: After Neisseria gonorrhoeae FC428 was first found in Japan, ceftriaxone-resistant strains disseminated globally, and the gonococcal resistance rate... After FC428 was first found in Japan, ceftriaxone-resistant strains disseminated globally, and the gonococcal resistance rate increased remarkably.... Background: After Neisseria gonorrhoeae FC428 was first found in Japan, ceftriaxone-resistant strains disseminated globally, and the gonococcal resistance rate... |
SourceID | doaj pubmedcentral proquest pubmed crossref informaworld |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 344 |
SubjectTerms | Anti-Bacterial Agents - pharmacology Antibiotics Antimicrobial Agents Azithromycin - pharmacology Ceftriaxone - pharmacology ceftriaxone-resistant China - epidemiology Ciprofloxacin - pharmacology Drug resistance Drug Resistance, Bacterial epidemiological investigation Genome, Bacterial Genomes Gonorrhea Gonorrhea - drug therapy Gonorrhea - microbiology Humans Microbial Sensitivity Tests Molecular Epidemiology Multilocus Sequence Typing N. gonorrhoeae Neisseria gonorrhoeae - classification Neisseria gonorrhoeae - drug effects Neisseria gonorrhoeae - genetics Neisseria gonorrhoeae - isolation & purification penA 60.001 Penicillin Spectinomycin - pharmacology |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NatwwEBYlp0Ip_a_btKjQQwt1s5ZkSz5um2ZDoSHQBnIz1t8mkMhh7YXmlnfoU_U1-iSdkb2LNxT20pMXW8IeaXbmkzTzDSFvuc1rbpxKleYsFcqLtBS1TK3VshaCGx9zYb4dFYcn4utpfjoq9YUxYT09cD9we-CuDMuZyo3GEyPAGxpctlXWAdYHMILWF3zeaDEVbbAEV5uJVcqOmuyBHwT0neOSkGWRurPAQh8jZxQ5-28xlv4Ld94Onxz5o4MH5P4AJOm0F-AhuePCI3Kv34WjfXLRY_J7H4_bMdoFx5_WwVIkZb108LMnI6GNp0hZnF5g9BA1zmMdj59NcCksxBFcho5euTClBUanZfTIxRP885rOm9AsFmeNqx1tY6mJlmK2CgVMSUH1wtw2YU5n0AysLugCvBQzVBpkhqbtso0RNTE495oe93Fi8GXvZvvpbPr9-P0HCuNX_Ln5BZfyCTk5-PLj82E6FG9IDcxPlwIO0LlmXrtSmkJazSZ1WWvnWOZ9LgqjmFeF0d55Zjh3MrdaewAPklmuCsWfkp0Awj4n1Bi4M7ETaXwmtPIqK0CfYOGbgYA-1wkRq1mszMBsjlJfVNlAgLqa_AonvxomPyEf192uemqPbR0-oYqsGyMzd7wB-loN-lpt09eElGMFq7q4MeP7KioV3_IBuyttrAZT01ZMCjXheSFZQt6sH4ORwJOfOrhmCW2gM8MdPp6QZ73yrqXgsOZF3reEyA213hBz80k4P4tE5AqMOeDBF_9jXF6SuwwzS2Kk0C7Z6RZL9wrwXqdfx7_2Xz3xTvY priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3NjtMwELZguSAhxD-BBRmJA0iYbWzHcU-osGxXSKxWgpV6i-K_7kqLU5pWghvvwFPxGjwJM05a2hViT40SW7UzY-eb8cw3hDwXrqiF9ZppIziTOkg2lHXJnDNlLaWwIeXCfDxShyfyw6SY9A63tg-rXO2JaaN2jUUf-R5YT3ogClXyN7OvDKtG4elqX0LjKrmG1GWo1eWkXPtYQJ2VzOUqcUcP9uBrCBi8QMOQ54nAU2G5j41PUmLuv8Bb-i_0eTGIcuOrdHCL3OzhJB118r9Nrvh4h9zofHG0SzG6S37t46E7xrygFGgdHUVq1i8eLjtKEtoEisTF7BxjiKj1Aat5fGuiZ2COI8SMCzrzcUQVxqjl9Minc_yzmk6b2Mznp42vPW1TwYmWYs4KBWRJQQHj1DVxSsfQDPZe0Aj4U8xTaZAfmrbLNsXVpBDd7_S4ixaDkb0Y77Px6NPxy1cU3p_6_eMn_AzvkZOD95_fHbK-hAOzAKwWDNCAKQwPxg9Lq0pn-KAe1sZ7nodQSGU1D1pZE3zgVghfFs6YABCi5E5opcV9shNhsg8JtRbuDNygtCGXRgedK9AqMH9zmGAoTEbkSoqV7fnNcdbnVd7ToK6EX6Hwq174GXm97jbrCD4u6_AWVWTdGPm5041mPq365V4ByLK84LqwBs85ASUbeB9OOw8WKkDojAw3FaxaJPdM6GqpVOKSAeyutLHqN5y2-rs8MvJs_Ri2Cjz_qaNvltAGOnP084mMPOiUdz0LAZYvsr9lpNxS661pbj-JZ6eJjlzDlg6o8NH_h_WYXOeYOZIigXbJzmK-9E8Azy3M07Ro_wAXrEg2 priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3da9RAEF9qfRFE_DZaZQUfFEy97G6ymweR09orQktBD_oWsl_XwplokoP2L_TfcmaTHL1S6YNvR7LLZXZmd3-zO_MbQt5wm5bcOBUrzVkslBdxLkoZW6tlKQQ3PuTCHB5lB3Px7SQ92SIjocIwgO21rh3Wk5o3y93z3xefYMJ_HCLkPsAWB8A6RW-PJYGVM0vULXIbNieJRQ0OB8QfFmcJe3Aixlyef_Xe2KUCmf8VKtPrAOnVuMpLG9X-fXJvQJh02pvEA7Llqofkbn88R_uso0fkzx7ew2MYDCqGlpWlyNb608HPnqWE1p4il3G8xLAiapzHAh_ndeVi8NARdVYdhaGa0gzD1hJ65MLV_llJF3VVN81p7UpH21CDoqWYxkIBbFKwyWph62pBZ9AMlmMwEvhTTF2pkTKatqs2hNqEqN0LetwHkMGXvZ3txbPp9-N37ymMXwYzL8kfk_n-1x9fDuKhpkNsAGl1McADnWrmtculyaTVbFLmpXaOJd6nIjOKeZUZ7Z1nhnMnU6u1B0whmeUqU_wJ2a5A1GeEGgNPJnYijU-EVl4lGZgZ-MMJiOdTHREx6rAwA-E5yrwskoEXdVR9gaovBtVHZHfd7VfP-HFTh89oIOvGSNgdHtTNohjmfwGoy7CUqdRovPgE2KxhPKyyDlxWwNQRyS-bV9GF8xrfF1cp-A0fsDPaYjFOoIJJoSY8zSSLyOv1a1g78EKorFy9gjbQmeHBH4_I095011JwcIWRDi4icsOoN8TcfFOdnQZ-cgVrPMDE5_8h0gtyh2GeSYgb2iHbXbNyLwH9dfpVmM9_AULpUiw priority: 102 providerName: Scholars Portal |
Title | Dissemination and genome analysis of high-level ceftriaxone-resistant penA 60.001 Neisseria gonorrhoeae strains from the Guangdong Gonococcal antibiotics susceptibility Programme (GD-GASP), 2016-2019 |
URI | https://www.tandfonline.com/doi/abs/10.1080/22221751.2021.2011618 https://www.ncbi.nlm.nih.gov/pubmed/34994305 https://www.proquest.com/docview/2748035672 https://www.proquest.com/docview/2618235403 https://pubmed.ncbi.nlm.nih.gov/PMC8794061 https://doaj.org/article/015c25285cb8425193b562d8de287656 |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1db9MwFLVge0FCiO8FRmUkHkAikNiO7T52bGuFtKoCJo2nKHbsbtJIpiaV4Bfyt7jXSap1Au2Bl6hKbDU3vrbPtc89JuQNL7OCW6djbTiLhfYiHotCxWVpVCEEtz7kwpzM5exUfD7LBjZh09MqMYb2nVBEGKuxcxemGRhxH2FKAyCdYXTH0qDCKVN9l-zCTJzgIQbJ99lmmQU8WopUDLk7_6q9NSsF8f4b0qV_A6A3eZTXJqbjh-RBjyjppHOBR-SOqx6T-91yHO2yjJ6Q34e47460F2wICqZTVGf94eBnp0pCa09Ruzi-RBoRtc7jgR4_68rFEJEjyqxaeuWqCZVIU0vp3IWt_IuCLuuqXq3Oa1c42oQzJxqKaSsUwCUFH6yWZV0t6RSKwfALTgF_iqkqNUpE02bdBGpNYOn-oouOMAZv9nZ6GE8nXxfv3lP4fhJ6Wjp-Sk6Pj759msX9GQ6xBWTVxgAHTGaYN26srFSlYUkxLoxzLPU-E9Jq5rW0xjvPLOdOZaUxHjCEYiXXUvNnZKcCU_cItRbuJGWirE-F0V6nEtwK4t8UzPOZiYgY2jC3vcA52nyZp70O6tD0OTZ93jd9RD5sql11Ch-3VThAB9kURoHucKNeLfO-v-eAsizLmM6swY1OgMkGvkepSwchKmDoiIyvu1fehvUZ3x2mkvNbXmB_8MW8H3GanCmhE55JxSLyevMYxgrcACoqV6-hDFRmuNDHI_K8c92NFRxCX5R_i4jacuotM7efVBfnQY9cw5gOsPDFf5j0ktxjmFcSeEL7ZKddrd0rQHutGYX-DFd1pkZk9-BovvgyCisncD0R-g9y3U_b |
linkProvider | Taylor & Francis |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtNAEF2V8gASQtwxFFgkkEDC1N71ZfOAUCA0Kb2oEq2UN9d7SysVO8SJoG_8A__Bf_AbfAkzazskFaJPfXJk7zq7ntm57M6cIeQZ13HOlRG-kJz5kbCR34ny1NdapnkUcWVdLszObjI4iD4O4-EK-dnmwmBYZSsTnaDWpcI98nXwnkTA4yRlb8dffKwahaerbQmNmi22zOlXcNmqN5s9oO9zxjY-7L8f-E1VAV-Brp_6oKBkLJmVppOqJNWSBXknl8aw0No4SpRgViRKWmOZ4tyksZbSglZLmeYiERzee4lcBsUboLOXDtP5ng4snyQKozZRSATroH3B5o_REWWhAwxNsLzIggp0lQLO4KT-y9o9G7S5oAU3bpDrjflKuzW_3SQrprhFrtV7f7ROabpNfvXwkB9jbJDqNC80RSjYzwZ-1hAotLQUgZL9E4xZospYrB7yrSyMD-4_mrTFlI5N0aUJxsSFdNe4uIHjnI7KopxMjkqTG1q5AhcVxRwZCpYsBYYvRrosRrQPzUDWAwfCn2JeTIl41LSaVS6Ox4UEn9K9OjoNRvai3_P73U97L19R-H7J7-8_4NK5Qw4uhLh3yWoBk71PqFJwJ9BBqmwYSWFFmAAXg7sdwgRtLD0StVTMVIOnjrM-ycIGdrUlfobEzxrie-T1vNu4BhQ5r8M7ZJF5Y8QDdzfKyShrxEsGRp1iMROxkniuCla5hO-hhTbgEYPJ7pHOIoNlU7cdZOvaLRk_ZwBrLTdmjYCrsr_L0SNP549BNOF5U16YcgZtoDPDfUXukXs1885nwcHTRrQ5j6RLbL00zeUnxfGRgz8XoELACn3w_2E9IVcG-zvb2fbm7tZDcpVh1oqLQlojq9PJzDwCW3IqH7sFTMnhRUuMPxq1huE |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bi9QwFA66gggi3q2uGsEHBbtOc2vmcXTcGW_DgC7oU2luswtrO0xnQH-hf8tz0nbYWZR98K20Ce1pTpLvJN_5Qshz7mTJrdepNpylQgeRDkWZp86ZvBSC2xBzYT7P1PRIfPgmezZh09EqMYYOrVBEHKuxcy9d6Blxr2FKAyAtMbpjWVThVJm-TK5ImHvx9IbB9-l2mQU8WolM9Lk7_6q9MytF8f5z0qV_A6DneZRnJqbDm-RGhyjpqHWBW-SSr26T6-1yHG2zjO6Q32Pcd0faCzYEBdMpqrP-8HDZqpLQOlDULk5PkUZErQ94oMfPuvIpROSIMqs1XfpqRBXS1DI683Er_6Ski7qqV6vj2peeNvHMiYZi2goFcEnBB6uFq6sFnUAxGH7BKeClmKpSo0Q0bTZNpNZElu4vOm8JY_BlLybjdDL6Mn_5isL_U9DTsuFdcnT47uvbadqd4ZBaQFbrFOCAkYYF44e5VbkzbFAOS-M9y0KQQlnNglbWBB-Y5dzn0hkTAEPkzHGtNL9H9iow9QGh1sKdgRvkNmTC6KAzBW4F8W8G5gVpEiL6NixsJ3CONp8WWaeD2jd9gU1fdE2fkINttWWr8HFRhTfoINvCKNAdb9SrRdH19wJQlmWSaWkNbnQCTDbwP5x2HkJUwNAJGZ51r2Id12dCe5hKwS_4gP3eF4tuxGkKlgs94FLlLCHPto9hrMANoLLy9QbKQGWGC308Ifdb191awSH0Rfm3hOQ7Tr1j5u6T6uQ46pFrGNMBFj78D5Oekqvz8WHx6f3s4yNyjWGKSaQM7ZO99WrjHwPwW5snsWv_ASJwTig |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dissemination+and+genome+analysis+of+high-level+ceftriaxone-resistant+penA+60.001+Neisseria+gonorrhoeae+strains+from+the+Guangdong+Gonococcal+antibiotics+susceptibility+Programme+%28GD-GASP%29%2C+2016-2019&rft.jtitle=Emerging+microbes+%26+infections&rft.au=Lin%2C+Xiaomian&rft.au=Chen%2C+Wentao&rft.au=Xie%2C+Qinghui&rft.au=Yu%2C+Yuqi&rft.date=2022-12-01&rft.pub=Taylor+%26+Francis&rft.eissn=2222-1751&rft.volume=11&rft.issue=1&rft.spage=344&rft.epage=350&rft_id=info:doi/10.1080%2F22221751.2021.2011618&rft.externalDBID=0YH&rft.externalDocID=2011618 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2222-1751&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2222-1751&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2222-1751&client=summon |